Quick Answer
Voyager Therapeutics, Inc. reported Stockholders Equity of $196.08 million for fiscal year 2025.
Voyager Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $196.08M | -34.6% |
| 2024 | $299.76M | +26.8% |
| 2023 | $236.32M | +300.4% |
| 2022 | $59.02M | -37.9% |
| 2021 | $95.06M | -38.4% |
| 2020 | $154.32M | +55.1% |
| 2019 | $99.51M | +114.3% |
| 2018 | $46.45M | -65.4% |
| 2017 | $134.05M | -1.4% |
| 2016 | $135.92M | -19.6% |
| 2015 | $169.07M | +911.7% |
| 2014 | -$20.83M | -443.4% |
| 2013 | -$3.83M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $219.82M | -33.4% | -9.9% |
| June 30, 2025 | $243.94M | -27.3% | -10.5% |
| March 31, 2025 | $272.70M | -20.0% | -9.0% |
| December 31, 2024 | $299.76M | +26.8% | -9.2% |
| September 30, 2024 | $330.31M | +87.4% | -1.5% |
| June 30, 2024 | $335.42M | +68.5% | -1.6% |
| March 31, 2024 | $340.89M | +57.1% | +44.2% |
| December 31, 2023 | $236.32M | +300.4% | +34.1% |
- Voyager Therapeutics, Inc. showed a decrease of -34.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, Voyager Therapeutics, Inc.’s stockholders equity has grown by 5215.6% (from -$3.83 million to $196.08 million).
- The most recent figure is from Voyager Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: